C CHARLES RIV LABS INTL INC
| Market Cap | $8.56B |
| P/E Ratio | — |
| Forward P/E | 14.12 |
| Dividend Yield | — |
| Beta | 1.62 |
| 52W Range | $99.75 - $226.77 |
| # Hedge Funds | 2 |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
Hedge Fund Ownership
| Investor 2 | % of Portfolio Weight of this stock in the investor's portfolio | Value Total dollar value of the position | Shares Number of shares held | Activity Portfolio change type: New, Increased, Decreased, or Sold |
|---|---|---|---|---|
| Charles Bobrinskoy Ariel Investments | 3.08% | $284.81M | 1,427,771 | Reduce 4.18% |
| Bill Nygren Harris Associates LP | 0.42% | $334.65M | 1,677,606 | Add 13.88% |
Insider Trading
| Insider Name of the company insider who made the trade 1 | Type Purchase (buy) or Sale (sell) | Shares Number of shares traded | Price Price per share at time of transaction | Value Total dollar value of the transaction | Trade Date Date the transaction was executed | Filing Date Date the SEC filing was submitted |
|---|---|---|---|---|---|---|
| LaPlume Joseph WEVP, Corp Strategy & Develop | Buy | 25 | $174.54 | $4.36K | 03 Mar 2026 | 04 Mar 2026 |
Frequently Asked Questions
What is CRL stock price today?
CHARLES RIV LABS INTL INC (CRL) is currently trading at $173.89. The stock has a 52-week range of $99.75 to $226.77 and a market capitalization of $8.56B.
Is CRL a good stock to buy in 2026?
CHARLES RIV LABS INTL INC has a P/E ratio of N/A (forward P/E: 14.1), a dividend yield of none, and 1-year performance of +23.3%. 2 hedge funds hold this stock. Review the fundamentals and ownership data above to make an informed decision.
Are insiders buying or selling CRL stock?
There have been 1 insider transactions for CRL in recent months. Insider buys can signal management confidence, while sales may reflect diversification or personal financial planning. Check the Insider Trading section above for details.
How has CRL stock performed over the past year?
CHARLES RIV LABS INTL INC (CRL) has returned +23.3% over the past 12 months. The stock traded between $99.75 and $226.77 during this period, and is currently at $173.89.
Which hedge funds own CRL (CHARLES RIV LABS INTL INC)?
2 tracked hedge funds currently hold CRL in their portfolios as of the latest 13F filings. See the ownership table above for the complete list.
What is CRL's market cap and valuation?
CHARLES RIV LABS INTL INC (CRL) has a market capitalization of $8.56B. The trailing P/E ratio is N/A and forward P/E is 14.1. The stock is classified in the Healthcare sector.
What is CRL's revenue and profitability?
CHARLES RIV LABS INTL INC reported revenue of $4.02B with net income of N/A and a profit margin of N/A. The stock has a beta of 1.62.
What sector is CRL in and who are its biggest institutional holders?
CHARLES RIV LABS INTL INC (CRL) operates in the Healthcare sector. It is held by 2 tracked hedge funds. See the ownership table above for the complete list.